Michael Peng
About Michael Peng
Michael Peng is the Lead Epidemiologist at Bristol Myers Squibb in Summit, New Jersey, with extensive experience in pharmacoepidemiology and regulatory affairs.
Current Role at Bristol Myers Squibb
Michael Peng is the Lead Epidemiologist at Bristol Myers Squibb, based in Summit, New Jersey, United States. In this role, he provides expert guidance in the analysis of large healthcare databases like MarketScan, CPRD, Kaiser, and Optum. He focuses on addressing safety and benefit-risk questions through pharmacoepidemiologic research. Additionally, Michael contributes to the development of study protocols and clinical study reports, providing content expertise for regulatory documents and communications with health authorities globally.
Previous Positions at Celgene and Roche
Before joining Bristol Myers Squibb, Michael Peng served as the Senior Director of PV and Epidemiology at Celgene from 2011 to 2019. Prior to his tenure at Celgene, he worked as an Associate Director of Epidemiology at Roche from 2008 to 2011. His roles at Celgene and Roche involved managing epidemiologic research and providing critical input for regulatory submissions and health agency queries.
Experience at Cardinal Health and Decision Resources
Michael Peng has also held pivotal roles early in his career as an Epidemiologist. From 2005 to 2007, he worked at Cardinal Health as an Epidemiologist, focusing on pharmacoepidemiologic research. Before that, he was an Epidemiologist at Decision Resources from 2002 to 2005. These positions provided him with extensive experience in analyzing health data and developing epidemiologic strategies.
Educational Background in Epidemiology and Microbiology
Michael Peng received his PhD in Epidemiology from the University of Michigan, where he studied from 1997 to 2001. He also holds an MPH in Epidemiology from Yale University School of Medicine, obtained between 1995 and 1997. Additionally, Michael earned a BS in Microbiology from the University of Rochester, completing his undergraduate studies from 1988 to 1992. His comprehensive academic background has equipped him with deep expertise in epidemiological and microbiological research.
Regulatory Expertise and Global Health Agency Interactions
Michael Peng is well-versed in interacting with health agencies globally, addressing their queries and providing content expertise for regulatory documents and submissions. He often contributes to PASS protocols and clinical study reports, ensuring regulatory compliance and effective communication with health authorities. His extensive experience in the field supports his role in guiding pharmacoepidemiologic research to answer critical questions on drug safety and benefit-risk assessments.